Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05558059 · ClinicalTrials.gov registry record
Imaging Retinal Vasculature in Infant Eyes
A clinical trial of Retinopathy of Prematurity, sponsored by Duke University.
- Recruiting
- Registry status
- 16
- Enrollment target
- 2
- Study locations
NCT05558059 is a study of Retinopathy of Prematurity that is actively recruiting participants, run by Duke University. The registered enrollment target is 16 participants, below the 367-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05558059, a study of Retinopathy of Prematurity, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.
Conditions Studied
Interventions
- DEVICE Handheld Optical Coherence Tomography with OCT Angiography
Study Locations (2)
North Carolina
- Duke University - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2027-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05558059
The ClinicalTrials.gov registry entry for NCT05558059 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 367-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Handheld Optical Coherence Tomography with OCT Angiography is the first listed.
NCT05558059 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05558059 about?
NCT05558059 is a clinical study titled "Imaging Retinal Vasculature in Infant Eyes". Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood v...
What is the current status of trial NCT05558059?
This trial is currently recruiting. The enrollment target is 16 participants. The study started on 2024-10-03. Estimated completion is 2027-08-31.
What conditions does trial NCT05558059 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity.
What interventions are being tested in trial NCT05558059?
The interventions under investigation include: Handheld Optical Coherence Tomography with OCT Angiography (DEVICE).
Who is sponsoring clinical trial NCT05558059?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05558059 being conducted?
This trial has 2 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical and Genetic Analysis of ROP
RECRUITING
-
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
RECRUITING · NA
-
Bevacizumab Treatment For Type 1 ROP
ACTIVE NOT RECRUITING · Phase 2
-
Validation of i-ROP DL to Detect More Than Mild ROP
ACTIVE NOT RECRUITING · NA
-
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
ACTIVE NOT RECRUITING
-
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.